Category: SICAV
Objective: The objective of the Fund is to increase the value of the Shareholder's investment over the long term (5 years or more). Investment Policy: The Fund invests mainly in equities of European companies. Derivatives and Techniques: : The Fund may use derivatives for hedging and for efficient portfolio management. Securities lending: Expected level: 20% of total net assets; maximum: 100%. Underlying securities in scope: equities. Benchmark (performance comparison):: The Fund's performance is compared against the MSCI Europe (EUR) Index (the “Benchmark” or the “Index”). The Fund does not base its investment process upon the Index so will not hold every component in the Index and may also hold equities that do not form part of it. The Fund is expected to have an average yearly tracking error of between 3% and 8% when compared to the Index. In certain conditions the Fund may be outside of this range. The Investment Manager actively makes the investment selection decisions for the Fund. You can buy and sell shares on demand on any full bank business day in Luxembourg. Recommendation: this Fund may not be appropriate for investors who plan to withdraw their money within 5 years. This is an accumulation share class and any income from the Fund will remain in the Fund and is reflected in the share price. For full investment objectives and policy details please refer to the Prospectus.
Closing Price 21/01/2021 | 10.25 |
Morningstar category | Europe Flex-Cap Equity |
Currency | EUR |
Distribution status | Accumulating |
ISIN | LU0010019577 |
Inception Date | 02/07/1990 |
Minimum initial amount | 100.00 EUR |
Entry fee | None |
Custody fee | None |
Exit fee | None |
Ongoing charge | 1.98% of which 1.00% is paid to MeDirect |
Address | Aviva Investors Luxembourg SA 2, rue du Fort Bourbon PO Box 1375 L-1249 Luxembourg Grand Duchy of Luxembourg Luxembourg L-1249 Luxembourg |
Manager Name | Edward Kevis |
Manager Start Date | 17/06/2016 |
Website | www.avivainvestors.com |
Total Net Assets (mil) | 95.24 EUR (31/12/2020) |
UCITS | Yes |
Administrator | J.P. Morgan Bank Luxembourg S.A. |
en 01/07/2020 |
en 14/07/2020 |
en 31/12/2019 |
en 30/06/2020 |
21/01/2021 |
Period | Annualised return | Date |
1 year | 0.26% | 20/01/2021 |
3 years | 0.12% | 20/01/2021 |
5 years | 4.04% | 20/01/2021 |
10 years | 6.43% | 20/01/2021 |
Since launch | 3.37% | 20/01/2021 |
Performance | |
YTD 01/01/2021 | 3.40 |
1 month | 4.54 |
3 months | 13.47 |
6 months | 11.93 |
Q 1 | Q 2 | Q 3 | Q 4 | |
2020 | -26.00% | 16.96% | 2.11% | 11.03% |
2019 | 11.63% | 4.93% | 0.03% | 7.94% |
2018 | -2.35% | 1.22% | -2.52% | -16.48% |
2017 | 5.86% | 2.69% | 1.44% | 2.04% |
% Long | % Short | % Net Assets | |
Stock | 99.31% | 0.00% | 99.31% |
Bond | 0.00% | 0.00% | 0.00% |
Cash | 0.69% | 0.00% | 0.69% |
Other | 0.00% | 0.00% | 0.00% |
Risk Measurement | 1 Year | 3 Years | 5 Years |
Standard Deviation | 29.46 | 19.73 | 16.51 |
Sharpe Ratio | 0.09 | 0.12 | 0.16 |
Sortino Ratio | 0.13 | 0.16 | 0.23 |
Positive Months | 7.00 | 20.00 | 35.00 |
Negative Months | 5.00 | 16.00 | 25.00 |
Worst Month | -16.60 | -16.60 | -16.60 |
Region | % |
Eurozone | 62.04 |
United Kingdom | 20.51 |
Europe - ex Euro | 12.53 |
United States | 3.41 |
Asia - Developed | 0.81 |
Sector | % of Equity |
Healthcare | 19.41 |
Financial Services | 16.68 |
Industrials | 13.58 |
Consumer Defensive | 11.23 |
Technology | 9.99 |
Consumer Cyclical | 8.90 |
Basic Materials | 5.57 |
Utilities | 5.48 |
Communication Services | 5.26 |
Energy | 1.87 |
Real Estate | 1.33 |
Holding | Sector | Country | % of Assets |
ASML Holding NV | Technology | Netherlands | 3.76 |
Nestle SA | Consumer Defensive | Switzerland | 3.43 |
Novartis AG | Healthcare | Switzerland | 3.23 |
Schneider Electric SE | Industrials | France | 3.01 |
SAP SE | Technology | Germany | 2.79 |
Prudential PLC | Financial Services | United Kingdom | 2.55 |
London Stock Exchange Group PLC | Financial Services | United Kingdom | 2.43 |
Lonza Group Ltd | Healthcare | Switzerland | 2.31 |
Siemens AG | Industrials | Germany | 2.03 |
Essilorluxottica | Healthcare | France | 2.02 |
Ranking | 1 Year | 2 Years | 3 Years | 5 Years |
Top 25% | ||||
Category above the average | ||||
Category below the average | ||||
Bottom 25% |
Large | Size | |||
Mid | ||||
Small | ||||
Value | Blend | Growth | ||
Style |